Rabourn Amy Zaremba - Mar 13, 2025 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role: SVP of Finance
Signature: /s/ Amy Rabourn
Stock symbol: IRD
Transactions as of: Mar 13, 2025
Transactions value $: $0
Form type: 4
Date filed: 3/17/2025, 08:54 PM
Previous filing: Feb 6, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRD	Common Stock	Award	$0	+39.5K	+53.04%	$0.00	114K	Mar 13, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IRD	Employee Stock Option (right to buy)	Award	$0	+39.5K		$0.00	39.5K	Mar 13, 2025	Common Stock	39.5K	$0.93	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.
F2	The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.